Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

PROTARA THERAPEUTICS, INC.

(TARA)
RiassuntoQuotazioniGraficiNotizieRatingAgendaSocietąFinanzaConsensusRevisioniDerivati 
 RiassuntoTutte le notizieRaccomandazione analistiAltre lingueComunicati stampaPubblicazioni ufficialiNotizie del settore
Tutte le notizie su PROTARA THERAPEUTICS, INC.
30/08PROTARA THERAPEUTICS, INC.: da BofA Securities è Buy
MM
04/06PROTARA THERAPEUTICS, INC.: HC Wainwright conferma il rating Buy
MM
18/02PROTARA THERAPEUTICS, INC.: Oppenheimer ottimista sul caso
MM
Tutte le notizie
Notizie in altre lingue su PROTARA THERAPEUTICS, INC.
18/10PROTARA THERAPEUTICS, INC.: Change in Directors or Principal Officers, Other Events, Fina..
18/10Protara Therapeutics, Inc. Announces Management Changes
12/10PROTARA THERAPEUTICS: Thinking about buying stock in Protara Therapeutics, Standard Lithi..
12/10Wall Street Set for Cautiously Higher Open, Earnings Season Eyed
12/10PROTARA THERAPEUTICS: FDA Clears Protara's TARA-002 Trial in Non-Muscle Invasive Bladder ..
12/10PROTARA THERAPEUTICS: FDA Clears IND Application for TARA-002 in Bladder Cancer
12/10PROTARA THERAPEUTICS: Announces FDA Clearance of Investigational New Drug Application for..
12/10PROTARA THERAPEUTICS, INC.: Regulation FD Disclosure, Other Events, Financial Statements ..
12/10PROTARA THERAPEUTICS: Announces FDA Clearance of Investigational New Drug Application for..
12/10Protara Therapeutics, Inc. Announces FDA Clearance of Investigational New Drug Applicat..
Pił notizie
Raccomandazione degli analisti su PROTARA THERAPEUTICS, INC.
30/08PROTARA THERAPEUTICS, INC.: da BofA Securities è Buy
MM
04/06PROTARA THERAPEUTICS, INC.: HC Wainwright conferma il rating Buy
MM
18/02PROTARA THERAPEUTICS, INC.: Oppenheimer ottimista sul caso
MM
Pił raccomandazioni